Current position: Home >> Scientific Research >> Paper Publications

DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo

Hits:

Institution:药学院

Title of Paper: DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo

Journal:J Pharmacy Pharmacology

First Author:郭秀丽

All the Authors:刘新泳

Document Code:lw-158882

Volume:66

Issue:3

Page Number:398

Translation or Not:No

Date of Publication:2014-03

Release Time:2019-10-22

Prev One:Combination treatment of Ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer

Next One:Heterocycle-thioacetic Acid Motif: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activities